6533b7d1fe1ef96bd125d570

RESEARCH PRODUCT

18P In vitro analysis of the combination of APR-246 and carboplatin in triple negative breast cancer (TNBC) and high grade serous ovarian cancer (HGSOC) cell lines and its impact on Aurora kinase A (AURKA)-p53 pathway

J.a. Perez FidalgoJ.j. Martinez-pretelK. EguezB. Ortega MorilloA. CervantesJ. HochstadtB. PinedaA. Lluch-hernandezM. Monzon

subject

P53 pathwaybusiness.industryHematologyCarboplatinIn vitro analysischemistry.chemical_compoundOncologychemistryCell cultureCancer researchSerous ovarian cancerMedicineAurora Kinase AbusinessTriple-negative breast cancerhttps://doi.org/10.1016/j.annonc.2021.08.296